{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:04:29Z","timestamp":1776089069896,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"canvector"},{"DOI":"10.13039\/501100001804","name":"canada research chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"canadian institutes of health research","doi-asserted-by":"publisher","award":["407306"],"award-info":[{"award-number":["407306"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"heart and stroke foundation of canada","doi-asserted-by":"publisher","award":["G-18-0022122"],"award-info":[{"award-number":["G-18-0022122"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"heart and stroke foundation of canada","doi-asserted-by":"publisher","award":["G-19-0026524"],"award-info":[{"award-number":["G-19-0026524"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00430-021-00725-2","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:03:06Z","timestamp":1642291386000},"page":"37-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality"],"prefix":"10.1007","volume":"211","author":[{"given":"Alexander","family":"Leatherdale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Stukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry E.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan L.","family":"Hoiland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl L.","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mypinder S.","family":"Sekhon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward L. G.","family":"Pryzdial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0081-0305","authenticated-orcid":false,"given":"Edward M.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,16]]},"reference":[{"key":"725_CR1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.abe6522","volume":"371","author":"JS Lavine","year":"2021","unstructured":"Lavine JS, Bjornstad ON, Antia R (2021) Immunological characteristics govern the transition of COVID-19 to endemicity. Science 371:741\u2013745","journal-title":"Science"},{"key":"725_CR2","doi-asserted-by":"crossref","unstructured":"Becker RC (2021) COVID-19 and its sequelae: a platform for optimal patient care, discovery and training. J Thromb Thrombolysis","DOI":"10.1007\/s11239-021-02375-w"},{"key":"725_CR3","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","volume":"117","author":"JC Holter","year":"2020","unstructured":"Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Tonby K, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Gj\u00f8lberg TT, Skeie LG, Hesstvedt L, Orm\u00e5sen V, Fevang B, Austad C, M\u00fcller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, M\u00fcller F, Aukrust P, Dudman S, Ueland T, Andersen JT, Lund-Johansen F, Heggelund L, Dyrhol-Riise AM, Mollnes TE (2020) Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc Natl Acad Sci USA 117:25018\u201325025","journal-title":"Proc Natl Acad Sci USA"},{"key":"725_CR4","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","volume":"136","author":"J Yu","year":"2020","unstructured":"Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA (2020) Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood 136:2080\u20132089","journal-title":"Blood"},{"key":"725_CR5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","volume":"98","author":"M Noris","year":"2020","unstructured":"Noris M, Benigni A, Remuzzi G (2020) The case of complement activation in COVID-19 multiorgan impact. Kidney Int 98:314\u2013322","journal-title":"Kidney Int"},{"key":"725_CR6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4049\/jimmunol.2000644","volume":"205","author":"MW Lo","year":"2020","unstructured":"Lo MW, Kemper C, Woodruff TM (2020) COVID-19: complement, coagulation, and collateral damage. J Immunol 205:1488\u20131495","journal-title":"J Immunol"},{"key":"725_CR7","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1111\/jth.15050","volume":"18","author":"EM Conway","year":"2020","unstructured":"Conway EM, Pryzdial EL (2020) Is the COVID-19 thrombotic catastrophe complement-connected? J Thromb Haemost 18:2812\u20132822","journal-title":"J Thromb Haemost"},{"key":"725_CR8","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","volume":"41","author":"GB Danzi","year":"2020","unstructured":"Danzi GB, Loffi M, Galeazzi G, Gherbesi E (2020) Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J 41:1858","journal-title":"Eur Heart J"},{"key":"725_CR9","doi-asserted-by":"crossref","unstructured":"Fox S, Akmatbekov A, Harbert J, Li G, Quincy Brown J, Vander Heide R (2020) Pulmonary and cardiac pathology in COVID-19: the first autopsy series from New Orleans. MedRxiv (preprint, not peer-reviewed)","DOI":"10.1101\/2020.04.06.20050575"},{"key":"725_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145\u2013147","journal-title":"Thromb Res"},{"key":"725_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3949\/ccjm.87a.ccc008","volume":"87","author":"LH Calabrese","year":"2020","unstructured":"Calabrese LH (2020) Cytokine storm and the prospects for immunotherapy with COVID-19. Cleve Clin J Med 87:389\u2013393","journal-title":"Cleve Clin J Med"},{"key":"725_CR12","unstructured":"Morgan BP (2000) The complement system: an overview. Methods Mol Biol (Clifton, NJ 150 (2000)."},{"key":"725_CR13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneph.2016.70","volume":"12","author":"D Ricklin","year":"2016","unstructured":"Ricklin D, Reis ES, Lambris JD (2016) Complement in disease: a defence system turning offensive. Nat Rev Nephrol 12:383\u2013401","journal-title":"Nat Rev Nephrol"},{"key":"725_CR14","doi-asserted-by":"crossref","first-page":"585108","DOI":"10.3389\/fimmu.2020.585108","volume":"11","author":"SR Barnum","year":"2020","unstructured":"Barnum SR, Bubeck D, Schein TN (2020) Soluble membrane attack complex: biochemistry and immunobiology. Front Immunol 11:585108","journal-title":"Front Immunol"},{"key":"725_CR15","first-page":"905","volume":"85","author":"C Gasser","year":"1955","unstructured":"Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 85:905\u2013909","journal-title":"Schweiz Med Wochenschr"},{"key":"725_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fped.2014.00097","volume":"2","author":"J Hofer","year":"2014","unstructured":"Hofer J, Rosales A, Fischer C, Giner T (2014) Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr 2:97","journal-title":"Front Pediatr"},{"key":"725_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/jcp.2008.056317","volume":"61","author":"DJ Unsworth","year":"2008","unstructured":"Unsworth DJ (2008) Complement deficiency and disease. J Clin Pathol 61:1013\u20131017","journal-title":"J Clin Pathol"},{"key":"725_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bst0320021","volume":"32","author":"RB Sim","year":"2004","unstructured":"Sim RB, Tsiftsoglou SA (2004) Proteases of the complement system. Biochem Soc Trans 32:21\u201327","journal-title":"Biochem Soc Trans"},{"key":"725_CR19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035\u20131050","journal-title":"J Am Soc Nephrol"},{"key":"725_CR20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0161-5890(99)00101-7","volume":"36","author":"MA Friese","year":"1999","unstructured":"Friese MA, Hellwage J, Jokiranta TS, Meri S, Peter HH, Eibel H, Zipfel PF (1999) FHL-1\/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol Immunol 36:809\u2013818","journal-title":"Mol Immunol"},{"key":"725_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molimm.2006.07.287","volume":"44","author":"JJ Alexander","year":"2007","unstructured":"Alexander JJ, Quigg RJ (2007) The simple design of complement factor H: looks can be deceiving. Mol Immunol 44:123\u2013132","journal-title":"Mol Immunol"},{"key":"725_CR22","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1182\/blood-2009-03-205096","volume":"114","author":"C Licht","year":"2009","unstructured":"Licht C, Pluthero FG, Li L, Christensen H, Habbig S, Hoppe B, Geary DF, Zipfel PF, Kahr WH (2009) Platelet-associated complement factor H in healthy persons and patients with atypical HUS. Blood 114:4538\u20134545","journal-title":"Blood"},{"key":"725_CR23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 361:345\u2013357","journal-title":"N Engl J Med"},{"key":"725_CR24","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","volume":"125","author":"R Cofiell","year":"2015","unstructured":"Cofiell R, Kukreja A, Bedard K, Yan Y, Mickle AP, Ogawa M, Bedrosian CL, Faas SJ (2015) Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Blood 125:3253\u20133262","journal-title":"Blood"},{"key":"725_CR25","doi-asserted-by":"crossref","first-page":"e0203","DOI":"10.1097\/CCE.0000000000000203","volume":"2","author":"S Stukas","year":"2020","unstructured":"Stukas S, Hoiland RL, Cooper J, Thiara S, Griesdale DE, Thomas AD, Orde MM, English JC, Chen LYC, Foster D, Mitra AR, Romano K, Sweet DD, Ronco JJ, Kanji HD, Chen Y-WR, Wong SL, Wellington CL, Sekhon MS (2020) The association of inflammatory cytokines in the pulmonary pathophysiology of respiratory failure in critically ill patients with coronavirus disease 2019. Crit Care Explor 2:e0203\u2013e0203","journal-title":"Crit Care Explor"},{"key":"725_CR26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/ki.1991.298","volume":"40","author":"M Oppermann","year":"1991","unstructured":"Oppermann M, Kurts C, Zierz R, Quentin E, Weber MH, Gotze O (1991) Elevated plasma levels of the immunosuppressive complement fragment Ba in renal failure. Kidney Int 40:939\u2013947","journal-title":"Kidney Int"},{"key":"725_CR27","doi-asserted-by":"crossref","first-page":"e007818","DOI":"10.1161\/JAHA.117.007818","volume":"7","author":"D Jalal","year":"2018","unstructured":"Jalal D, Renner B, Laskowski J, Stites E, Cooper J, Valente K, You Z, Perrenoud L, Le Quintrec M, Muhamed I, Christians U, Klawitter J, Lindorfer MA, Taylor RP, Holers VM, Thurman JM (2018) Endothelial microparticles and systemic complement activation in patients with chronic kidney disease. J Am Heart Assoc 7:e007818","journal-title":"J Am Heart Assoc"},{"key":"725_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM198502143120702","volume":"312","author":"JE Volanakis","year":"1985","unstructured":"Volanakis JE, Barnum SR, Giddens M, Galla JH (1985) Renal filtration and catabolism of complement protein D. N Engl J Med 312:395\u2013399","journal-title":"N Engl J Med"},{"key":"725_CR29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97:829\u2013838","journal-title":"Kidney Int"},{"key":"725_CR30","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/jmv.26844","volume":"93","author":"IH Tanbo\u011fa","year":"2021","unstructured":"Tanbo\u011fa IH, Canpolat U, \u00c7etin EH\u00d6, Kundi H, Celik O, Ca\u011flayan M, Ata N, \u00d6zeke \u00d6, \u00c7ay S, Kaymaz C, Topalo\u011flu S (2021) Development and validation of clinical prediction models to estimate the probability of death in hospitalized patients with COVID-19: insights from a Nationwide Database. J Med Virol 93:3015\u20133022","journal-title":"J Med Virol"},{"key":"725_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","volume":"146","author":"M Cugno","year":"2020","unstructured":"Cugno M, Meroni PL, Gualtierotti R, Griffini S, Grovetti E, Torri A, Panigada M, Aliberti S, Blasi F, Tedesco F, Peyvandi F (2020) Complement activation in patients with COVID-19: a novel therapeutic target. J Allergy Clin Immunol 146:215\u2013217","journal-title":"J Allergy Clin Immunol"},{"key":"725_CR32","doi-asserted-by":"crossref","unstructured":"Gao T, Hu M, Zhang X, Li H, Zhu L, Kuiu H, D. Q, Zhang Z, Wang Z, Hu Y, Fu Y, Jin Y, Li K, Zhao S, Xiao Y, Luo S, Li L, Zhao L, Liu J, Zhao H, Liu Y, Yang W, Peng J, Chen X, Li P, Liu Y, Xie Y, Song JJ, Zhang L, Ma Q, Bian X, Chen W, Liu X, Mao Q, Cao C (2020) Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. MedRxiv (preprint, not peer-reviewed)","DOI":"10.1101\/2020.03.29.20041962"},{"key":"725_CR33","doi-asserted-by":"crossref","first-page":"663187","DOI":"10.3389\/fimmu.2021.663187","volume":"12","author":"G Sinkovits","year":"2021","unstructured":"Sinkovits G, Mezo B, Reti M, Muller V, Ivanyi Z, Gal J, Gopcsa L, Remenyi P, Szathmary B, Lakatos B, Szlavik J, Bobek I, Prohaszka ZZ, Forhecz Z, Csuka D, Hurler L, Kajdacsi E, Cervenak L, Kiszel P, Masszi T, Valyi-Nagy I, Prohaszka Z (2021) Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection. Front Immunol 12:663187","journal-title":"Front Immunol"},{"key":"725_CR34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/infdis\/jiaa646","volume":"223","author":"AH de Nooijer","year":"2021","unstructured":"de Nooijer AH, Grondman I, Janssen NAF, Netea MG, Willems L, van de Veerdonk FL, Giamarellos-Bourboulis EJ, Toonen EJM, Joosten LAB, R.-C.-s. group (2021) Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes. J Infect Dis 223:214\u2013224","journal-title":"J Infect Dis"},{"key":"725_CR35","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/429631","volume":"191","author":"WK Ip","year":"2005","unstructured":"Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Jensenius JC, Turner MW, Peiris JS, Lau YL (2005) Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 191:1697\u20131704","journal-title":"J Infect Dis"},{"key":"725_CR36","doi-asserted-by":"crossref","first-page":"714511","DOI":"10.3389\/fimmu.2021.714511","volume":"12","author":"YM Ali","year":"2021","unstructured":"Ali YM, Ferrari M, Lynch NJ, Yaseen S, Dudler T, Gragerov S, Demopulos G, Heeney JL, Schwaeble WJ (2021) Lectin pathway mediates complement activation by SARS-CoV-2 proteins. Front Immunol 12:714511","journal-title":"Front Immunol"},{"key":"725_CR37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1078\/0171-2985-00155","volume":"205","author":"NM Thielens","year":"2002","unstructured":"Thielens NM, Tacnet-Delorme P, Arlaud GJ (2002) Interaction of C1q and mannan-binding lectin with viruses. Immunobiology 205:563\u2013574","journal-title":"Immunobiology"},{"key":"725_CR38","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fmicb.2017.01117","volume":"8","author":"P Agrawal","year":"2017","unstructured":"Agrawal P, Nawadkar R, Ojha H, Kumar J, Sahu A (2017) Complement evasion strategies of viruses: an overview. Front Microbiol 8:1117","journal-title":"Front Microbiol"},{"key":"725_CR39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.ATV.0000206211.21895.73","volume":"26","author":"SR Ji","year":"2006","unstructured":"Ji SR, Wu Y, Potempa LA, Liang YH, Zhao J (2006) Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 26:935\u2013941","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"725_CR40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molimm.2017.05.012","volume":"89","author":"G Arbore","year":"2017","unstructured":"Arbore G, Kemper C, Kolev M (2017) Intracellular complement\u2014the complosome\u2014in immune cell regulation. Mol Immunol 89:2\u20139","journal-title":"Mol Immunol"},{"key":"725_CR41","doi-asserted-by":"crossref","first-page":"abg0833","DOI":"10.1126\/sciimmunol.abg0833","volume":"6","author":"B Yan","year":"2021","unstructured":"Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, Zhang CJ, Nichols EM, Malik N, Gregory R, Bantscheff M, Ghidelli-Disse S, Kolev M, Frum T, Spence JR, Sexton JZ, Alysandratos KD, Kotton DN, Pittaluga S, Bibby J, Niyonzima N, Olson MR, Kordasti S, Portilla D, Wobus CE, Laurence A, Lionakis MS, Kemper C, Afzali B, Kazemian M (2021) SARS-CoV-2 drives JAK1\/2-dependent local complement hyperactivation. Sci Immunol 6:abg0833","journal-title":"Sci Immunol"},{"key":"725_CR42","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-33390\/v1","author":"B Yan","year":"2020","unstructured":"Yan B, Freiwald T, Chauss D, Wang L, West E, Bibby J, Olson M, Kordasti S, Portilla D, Laurence A, Lionakis MS, Kemper C, Afzali B, Kazemian M (2020) SARS-CoV2 drives JAK1\/2-dependent local and systemic complement hyper-activation. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-33390\/v1","journal-title":"Res Sq"},{"key":"725_CR43","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1074\/jbc.M109.044529","volume":"285","author":"AI Okemefuna","year":"2010","unstructured":"Okemefuna AI, Nan R, Miller A, Gor J, Perkins SJ (2010) Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J Biol Chem 285:1053\u20131065","journal-title":"J Biol Chem"},{"key":"725_CR44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00011-020-01342-0","volume":"69","author":"J Yuan","year":"2020","unstructured":"Yuan J, Zou R, Zeng L, Kou S, Lan J, Li X, Liang Y, Ding X, Tan G, Tang S, Liu L, Liu Y, Pan Y, Wang Z (2020) The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflamm Res 69:599\u2013606","journal-title":"Inflamm Res"},{"key":"725_CR45","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ (2020) Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents 55:105954","journal-title":"Int J Antimicrob Agents"},{"key":"725_CR46","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H (2020) Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA 117:10970\u201310975","journal-title":"Proc Natl Acad Sci USA"},{"key":"725_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-020-00961-x","author":"R Muhammad","year":"2021","unstructured":"Muhammad R, Ogunti R, Ahmed B, Munawar M, Donaldson S, Sumon M, Kibreab A, Thomas AN, Mehari A (2021) Clinical characteristics and predictors of mortality in minority patients hospitalized with COVID-19 infection. J Racial Ethnic Health Disparities. https:\/\/doi.org\/10.1007\/s40615-020-00961-x","journal-title":"J Racial Ethnic Health Disparities"},{"key":"725_CR48","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054\u20131062","journal-title":"Lancet"},{"key":"725_CR49","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","volume":"18","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z (2020) D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19. J Thromb Haemost 18:1324\u20131329","journal-title":"J Thromb Haemost"},{"key":"725_CR50","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/bjh.16797","volume":"190","author":"Y Li","year":"2020","unstructured":"Li Y, Zhao K, Wei H, Chen W, Wang W, Jia L, Liu Q, Zhang J, Shan T, Peng Z, Liu Y, Yan X (2020) Dynamic relationship between d-dimer and COVID-19 severity. Br J Haematol 190:e24\u2013e27","journal-title":"Br J Haematol"},{"key":"725_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.00001","volume":"9","author":"MG Da Costa","year":"2018","unstructured":"Da Costa MG, Poppelaars F, Van Kooten C, Mollnes TE, Tedesco F, W\u00fcrzner R, Trouw LA, Truedsson L, Daha MR, Roos A, Seelen MA (2018) Age and sex-associated changes of complement activity and complement levels in a healthy caucasian population. Front Immunol 9:1\u201314","journal-title":"Front Immunol"},{"key":"725_CR52","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4049\/jimmunol.147.3.927","volume":"147","author":"T Masaki","year":"1991","unstructured":"Masaki T, Matsumoto M, Yasuda R, Levine RP, Kitamura H, Seya T (1991) A covalent dimer of complement C4b serves as a subunit of a novel C5 convertase that involves no C3 derivatives. J Immunol 147:927\u2013932","journal-title":"J Immunol"},{"key":"725_CR53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.2020005959","volume":"137","author":"M Mannes","year":"2021","unstructured":"Mannes M, Dopler A, Zolk O, Lang SJ, Halbgebauer R, Hochsmann B, Skerra A, Braun CK, Huber-Lang M, Schrezenmeier H, Schmidt CQ (2021) Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity. Blood 137:443\u2013455","journal-title":"Blood"},{"key":"725_CR54","doi-asserted-by":"crossref","unstructured":"Chouaki Benmansour N, Carvelli J, Vivier E (2021) Complement cascade in severe forms of COVID-19: recent advances in therapy. Eur J Immunol","DOI":"10.1002\/eji.202048959"},{"key":"725_CR55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","volume":"588","author":"J Carvelli","year":"2020","unstructured":"Carvelli J, Demaria O, Vely F, Batista L, Chouaki-Benmansour N, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, Andre P, Represa A, Piperoglou C, C.-I.P.H.g. Explore, C.-M.I.g. Explore, Cordier PY, Le-Dault E, Guervilly C, Simeone P, Gainnier M, Morel Y, Ebbo M, Schleinitz N, Vivier E (2020) Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis. Nature 588:146\u2013150","journal-title":"Nature"},{"key":"725_CR56","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.it.2020.09.008","volume":"41","author":"TM Woodruff","year":"2020","unstructured":"Woodruff TM, Shukla AK (2020) The complement C5a\u2013C5aR1 GPCR axis in COVID-19 therapeutics. Trends Immunol 41:965\u2013967","journal-title":"Trends Immunol"},{"key":"725_CR57","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.jaci.2021.03.038","volume":"147","author":"W Posch","year":"2021","unstructured":"Posch W, Vosper J, Noureen A, Zaderer V, Witting C, Bertacchi G, Gstir R, Filipek PA, Bonn GK, Huber LA, Bellmann-Weiler R, Lass-Florl C, Wilflingseder D (2021) C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia. J Allergy Clin Immunol 147:2083-2097.e6","journal-title":"J Allergy Clin Immunol"},{"key":"725_CR58","first-page":"77","volume":"7","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y, Li J, Du L, Jiang S, Guo R, Sun S, Zhou Y (2018) Blockade of the C5a\u2013C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg Microbes Infect 7:77","journal-title":"Emerg Microbes Infect"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-021-00725-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-021-00725-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-021-00725-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T03:33:29Z","timestamp":1674444809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-021-00725-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,16]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1007\/s00430-021-00725-2","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,16]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}